Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
Wollring MM, Werner JM, Bauer EK, Tscherpel C, Ceccon GS, Lohmann P, Stoffels G, Kabbasch C, Goldbrunner R, Fink GR, Langen KJ, Galldiks N.
Wollring MM, et al. Among authors: galldiks n.
Neuro Oncol. 2023 May 4;25(5):984-994. doi: 10.1093/neuonc/noac229.
Neuro Oncol. 2023.
PMID: 36215231
Free PMC article.